[Federal Register: July 7, 2003 (Volume 68, Number 129)]
[Notices]               
[Page 40269-40270]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07jy03-80]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Public Health Laboratory Biomonitoring Implementation 
Program, Program Announcement 03034

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Public Health Laboratory Biomonitoring 
Implementation Program, Program Announcement 03034.
    Times and Dates: 8:30 a.m.-9:15 a.m., July 28, 2003 (Open), 9:15 
a.m.-4:30 p.m., July 28, 2003 (Closed).
    Place: J.W. Marriott, 3300 Lenox Road, NE., Atlanta, GA 30326, 
Telephone 404.262.3344.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and

[[Page 40270]]

evaluation of applications received in response to Program 
Announcement 03034.
    For Further Information Contact: Drue Barrett, Ph.D., Deputy 
Associate Director for Science, National Center for Environmental 
Health, CDC, 4770 Buford Highway, MS-F29, Atlanta, GA 30341, 
Telephone 770.488.7653.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 26, 2003.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 03-17017 Filed 7-3-03; 8:45 am]

BILLING CODE 4163-18-P